Please use this identifier to cite or link to this item:
Title: R&D, strategic alliances and shareholder value in biotech industry.
Authors: Teng, Poi Leng.
Keywords: DRNTU::Business::Industries and labor
Issue Date: 2004
Abstract: The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape proposals for improved information disclosure on organizational capital.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:NBS Theses

Files in This Item:
File Description SizeFormat 
  Restricted Access
19.58 MBAdobe PDFView/Open

Page view(s) 20

Updated on Jan 26, 2021


Updated on Jan 26, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.